Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05820308 · ClinicalTrials.gov registry record · NA

Companion Dog Walking for ICU Survivor Health

A NA study of Depression and Anxiety, sponsored by University of Missouri, Kansas City.

Completed
Registry status
NA
Development phase
6
Enrollment target
2
Study locations

NCT05820308 is a NA study of Depression and Anxiety that has completed, run by University of Missouri, Kansas City. The registered enrollment target is 6 participants, below the 786-participant average among 679 other Depression trials with a reported enrollment target (99% lower). The trial reports 2 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05820308, a NA study of Depression and Anxiety, has completed, sponsored by University of Missouri, Kansas City.

COMPLETED
Registry status
NA
Development phase
6 participants
Enrollment target
2
Study locations

Study Summary

The goal of this clinical trial is to determine the feasibility and acceptability of a randomized controlled trial comparing a pet dog walking intervention to an attention control education intervention in adult intensive care unit survivors. The main question\[s\] it aims to answer are: * What is the feasibility of a pet dog-walking intervention compared to an attention control education intervention on depression, anxiety, cortisol, and quality of life for adult ICU survivors. * What is the acceptability of a pet dog-walking intervention compared to an attention control education intervention on depression, anxiety, cortisol, and quality of life for adult ICU survivors. The secondary question\[s\] it aims to answer are: \- What are the differences in depression, anxiety, serum cortisol, and quality of life between and within a companion dog walking intervention compared to an attention control education intervention for ICU survivors? Participants in the intervention group will be asked to: * Participate in dog walking with their pet dog at least three times per week, for at least 10 minutes each walk, for 8-weeks. * Wear an activity monitor and record their dog walks in a diary. * Complete surveys to measure depression, anxiety, and quality of life at the start of the study, after week 4, and after week 8. * Have blood drawn to measure cortisol levels at the start of the study, after week 4, and after week 8. Participants in the control group will be asked to: * Read educational materials about their pet dog's health once every week (education materials are provided by the researchers). * Wear an activity monitor and record when they read their education materials in a diary. * Complete surveys to measure depression, anxiety, and quality of life at the start of the study, after week 4, and after week 8. * Have blood drawn to measure cortisol levels at the start of the study, after week 4, and after week 8. Participants will be assigned to an intervention

Interventions

  • BEHAVIORAL Attention Control Group
  • BEHAVIORAL Companion Dog Walking

Study Locations (2)

Colorado

  • Penrose Hospital - Colorado Springs
  • St. Francis Hospital - Colorado Springs

Trial Details

FieldValue
Enrollment Target 6 participants
Start Date 2023-05-15
Est. Completion 2024-05-01
Phase NA

What the Registry Record Tells You About NCT05820308

The ClinicalTrials.gov registry entry for NCT05820308 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 786-participant average among 679 other Depression trials with a reported enrollment target (99% lower). The listed sponsor is University of Missouri, Kansas City, which has 33 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with Depression appearing as the primary indexed condition, and to 2 interventions - of which Attention Control Group is the first listed.

NCT05820308 reports 2 study locations spanning 1 distinct geographic area - top geographies include Colorado.

Frequently Asked Questions

What is clinical trial NCT05820308 about?

NCT05820308 is a clinical study titled "Companion Dog Walking for ICU Survivor Health". The goal of this clinical trial is to determine the feasibility and acceptability of a randomized controlled trial comparing a pet dog walking intervention to an attention control education intervention in adult intensive care unit survivors. The main question\[s\] it aims to answer are: * What is...

What is the current status of trial NCT05820308?

This trial is currently completed. It is a NA study. The enrollment target is 6 participants. The study started on 2023-05-15. Estimated completion is 2024-05-01.

What conditions does trial NCT05820308 study?

This clinical trial studies the following conditions: Depression, Anxiety, Quality of Life, Post-Intensive Care Syndrome.

What interventions are being tested in trial NCT05820308?

The interventions under investigation include: Attention Control Group (BEHAVIORAL), Companion Dog Walking (BEHAVIORAL).

Who is sponsoring clinical trial NCT05820308?

This trial is sponsored by University of Missouri, Kansas City, which has 33 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05820308 being conducted?

This trial has 2 study locations across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Depression

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.